Terminated PHASE3 INTERVENTIONAL 4-arm NCT00024167

Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer

A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer

Sponsor: M.D. Anderson Cancer Center

Conditions Prostate Cancer

Interventions Dexamethasone Docetaxel Doxorubicin hydrochloride Estramustine phosphate sodium Ketoconazole Prednisone Strontium chloride Sr 89 Vinblastine

Updated 6 times since 2017 Last updated: Feb 19, 2016 Started: Apr 30, 2002 Primary completion: Sep 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Terminated due to slow accrual

Other terminated trials from M.D. Anderson Cancer Center

See all terminations from M.D. Anderson Cancer Center

Other Prostate Cancer trials with similar outcome

Browse all Prostate Cancer trials

Listed as NCT00024167, this PHASE3 trial focuses on Prostate Cancer and remains terminated or withdrawn. Sponsored by M.D. Anderson Cancer Center, it has been updated 6 times since 2002, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE3

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Terminated PHASE3

First recorded

Apr 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Data source: M.D. Anderson Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Akron, United States , Barberton, United States , Bettendorf, United States , Billings, United States , Bozeman, United States , Butte, United States , Dallas, United States , Davenport, United States , Florence, United States , Gainesville, United States and 16 more locations